Verastem | VSTM - Current Assets


Verastem reported $154.06M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Curis USD 14.42M 10.39M Jun/2025
Cytokinetics USD 916.97M 60.37M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
Incyte USD 5.02B 746.01M Dec/2025
Laboratory Of America USD 4.02B 58.3M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
TG Therapeutics USD 630.76M 31M Dec/2025
Verastem USD 154.06M 29.36M Sep/2025